comparemela.com

Latest Breaking News On - Jorge gallardo - Page 5 : comparemela.com

World recognition for Mthatha doctor

Mthatha-born Dr Pamela Mda has been chosen as one of the inaugural team of brilliant doctors from across the world to take part in a new scientific leadership development programme.

The Future of Virtual Healthcare , as Envisioned by the Current Crop of Big Pharma s Profiteering CEOs

The Future of Virtual Healthcare , as Envisioned by the Current Crop of Big Pharma s Profiteering CEOs
lewrockwell.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lewrockwell.com Daily Mail and Mail on Sunday newspapers.

Sunburn — The morning read of what s hot in Florida politics — 6 9 21

Almirall S A : net profit falls 39% in Q1 as it looks for M&A opportunities

Message : Required fields BARCELONA, May 10 (Reuters) - Spanish pharmaceuticals group Almirall said on Monday its first-quarter net profit fell 38.7% to 29.8 million euros ($36.2 million) and revenues by 10%, as the company looks for merger and acquisition (M&A) opportunities. The Barcelona-based firm continued to be hurt by the pandemic as mobility restrictions led to fewer patients going to the doctor, while sales suffered from generic competition in the United States. It said on Monday it predicts COVID-19 will continue to affect its operations in the first half, before its impact lessens in the second half of the year. With Gianfranco Nazzi recently sworn as chief executive

UPDATE 1-Spain s Almirall on lookout for U S dermatology opportunities

(Adds details) BARCELONA, May 7 (Reuters) - Spanish pharmaceuticals company Almirall is looking for new dermatology opportunities in the United States, Chairman Jorge Gallardo said on Friday. At a press conference, he also said the company maintains its 2021 outlook for core sales growth in a mid-single-digit percentage and core earnings before interest, taxes, depreciation, and amortisation (EBITDA) to be 190 million to 210 million euros ($231 million-$255 million), up from 181 million euros in 2020. The Barcelona-based company said in March, without disclosing the reason, it had decided not to exercise its right to acquire U.S. dermatological company Bioniz Therapeutics, for which it had made an initial payment of $15 million.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.